These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7683109)

  • 1. Carcinogenicity of azathioprine: an S-AR investigation.
    Gombar VK; Enslein K; Blake BW
    Mutat Res; 1993 May; 302(1):7-12. PubMed ID: 7683109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between molecular connectivity and carcinogenic activity: a confirmation with a new software program based on graph theory.
    Malacarne D; Pesenti R; Paolucci M; Parodi S
    Environ Health Perspect; 1993 Sep; 101(4):332-42. PubMed ID: 8275991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR prediction of rodent carcinogenicity for a set of chemicals currently bioassayed by the US National Toxicology Program.
    Benigni R
    Mutagenesis; 1991 Sep; 6(5):423-5. PubMed ID: 1795649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens.
    Mayer J; Cheeseman MA; Twaroski ML
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):50-8. PubMed ID: 18023949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the early-response genes in chemical-induced renal carcinogenicity for the prediction of chemical carcinogenicity in rats.
    Matsumoto H; Saito F; Takeyoshi M
    J Toxicol Sci; 2017; 42(2):175-181. PubMed ID: 28321044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular fragments associated with non-genotoxic carcinogens, as detected using a software program based on graph theory: their usefulness to predict carcinogenicity.
    Malacarne D; Taningher M; Pesenti R; Paolucci M; Perrotta A; Parodi S
    Chem Biol Interact; 1995 Jun; 97(1):75-100. PubMed ID: 7767943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of CASE predictions of genotoxic carcinogenesis for omeprazole, methapyrilene and azathioprine.
    Ashby J
    Mutat Res; 1992 Aug; 272(1):1-7. PubMed ID: 1380115
    [No Abstract]   [Full Text] [Related]  

  • 13. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants.
    Rosenkranz HS; Klopman G
    Mutat Res; 1990 Feb; 228(2):105-24. PubMed ID: 2300064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural analysis of the genotoxic and carcinogenic potentials of cyclosporin A.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1992 Mar; 7(2):115-8. PubMed ID: 1579066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophilicity as measured by Ke: molecular determinants, relationship with other physical-chemical and quantum mechanical parameters, and ability to predict rodent carcinogenicity.
    Benigni R; Cotta-Ramusino M; Andreoli C; Giuliani A
    Carcinogenesis; 1992 Apr; 13(4):547-53. PubMed ID: 1576705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of probability of carcinogenicity for a set of ongoing NTP bioassays.
    Enslein K; Blake BW; Borgstedt HH
    Mutagenesis; 1990 Jul; 5(4):305-6. PubMed ID: 2398815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine.
    Rep Carcinog; 2004; 11():III25-6. PubMed ID: 21089807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.